Atlas Trials

Sustained Effect of Urticaria Remission With Relatively High Dose Vitamin D Supplementation After Omalizumab Discontinuation

Clinical trial NCT02742805 · WITHDRAWN

Trial details

NCT number
NCT02742805
Sponsor
Selina Gierer, D.O.
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Urticaria
Start date
2016-02-01
Primary completion
2018-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.